Clinical Trials Directory

Trials / Completed

CompletedNCT02515747

Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE

Role of Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype in Prediction of Coronary Events in General Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,400 (actual)
Sponsor
Russian Cardiology Research and Production Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore the role of lipoprotein(a) and apolipoprotein(a) phenotype in fatal and non-fatal cardiovascular disease (CVD) events risk in coronary disease patients divided on the basis of management strategy - medical, endovascular or open cardiac surgery.

Detailed description

Between January 1993 and September 2006, we enrolled 1400 consecutive patients from the Atherosclerosis Department with known Lp(a) levels and coronary heart disease (CHD) verified by angiography. In accordance with clinical condition and angiography data were assigned them into three parallel treatment arms and followed up to 15 years. This study was conducted according to the principles of the Declaration of Helsinki and the Institutional Ethics Committee.

Conditions

Interventions

TypeNameDescription
PROCEDUREpercutaneous coronary interventionelective percutaneous coronary balloon angioplasty and/or stenting
PROCEDUREcoronary artery bypass graftingelective surgical myocardial revascularisation

Timeline

Start date
1993-01-01
Primary completion
2006-09-01
Completion
2014-01-01
First posted
2015-08-05
Last updated
2015-08-05

Source: ClinicalTrials.gov record NCT02515747. Inclusion in this directory is not an endorsement.